Cleft palate is among the most common birth defects in humans. Previous studies have shown that Shh signaling plays critical roles in palate development and regulates expression of several members of the forkhead-box (Fox) family transcription factors, including Foxf1 and Foxf2, in the facial primordia. Although cleft palate has been reported in mice deficient in Foxf2, whether Foxf2 plays an intrinsic role in and how Foxf2 regulates palate development remain to be elucidated. Using Cre/loxP-mediated tissue-specific gene inactivation in mice, we show that Foxf2 is required in the neural crest-derived palatal mesenchyme for normal palatogenesis. We found that Foxf2 mutant embryos exhibit altered patterns of expression of Shh, Ptch1, and Shox2 in the developing palatal shelves. Through RNA-seq analysis, we identified over 150 genes whose expression was significantly up-or down-regulated in the palatal mesenchyme in Funding: This work was supported by National Institutes of Health National Institute of Dental and Craniofacial Research grant DE013681 and DE018401 to RJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
control littermates. Whole mount in situ hybridization analysis revealed that the Foxf2 mutant embryos exhibit strikingly corresponding patterns of ectopic Fgf18 expression in the palatal mesenchyme and concomitant loss of Shh expression in the palatal epithelium in specific subdomains of the palatal shelves that correlate with where Foxf2, but not Foxf1, is expressed during normal palatogenesis. Furthermore, tissue specific inactivation of both Foxf1 and Foxf2 in the early neural crest cells resulted in ectopic activation of Fgf18 expression throughout the palatal mesenchyme and dramatic loss of Shh expression throughout the palatal epithelium. Addition of exogenous Fgf18 protein to cultured palatal explants inhibited Shh expression in the palatal epithelium. Together, these data reveal a novel ShhFoxf-Fgf18-Shh circuit in the palate development molecular network, in which Foxf1 and Foxf2 regulate palatal shelf growth downstream of Shh signaling, at least in part, by repressing Fgf18 expression in the palatal mesenchyme to ensure maintenance of Shh expression in the palatal epithelium.
Introduction
The mammalian secondary palate develops from the oral side of the embryonic maxillary processes as a pair of outgrowths, which initially grow vertically to form the palatal shelves flanking the developing tongue. As development proceeds, the palatal shelves reorient to the horizontal position above the dorsum of the tongue, grow towards and subsequently fuse with each other at the midline to form the roof of the oral cavity. Genetic or environmental perturbations of any of these developmental processes, including palatal shelf growth, elevation and fusion, cause cleft palate, one of the most common congenital birth defects in humans [1] [2] [3] [4] .
Previous studies have shown that palatal shelf growth is regulated by reciprocal signaling interactions between the epithelium and the underlying neural crest-derived mesenchyme. At the onset of the palatal outgrowth, the secreted signaling molecule Sonic hedgehog (Shh) is expressed in the oral epithelium [5] . Shh is a mitogen and promotes cell proliferation in many embryonic and adult tissues [6] . Explant culture assays indicate that exogenous Shh protein stimulates palatal mesenchyme proliferation [7, 8] . Tissue-specific inactivation of the Smoothened (Smo) gene, which encodes a transmembrane protein required for transduction of the Shh signaling, in the early cranial neural crest cells resulted in complete absence of secondary palate structures in the Smo c/n ;Wnt1-Cre mutant mice [9] . Moreover, tissue-specific inactivation of Shh in the oral epithelium or Smo in the early palatal mesenchyme resulted in defects in palatal shelf growth in the mutant mouse embryos [3, 8, 10] . Whereas the mechanism by which Shh signaling regulates palatal mesenchyme cell proliferation is incompletely understood, Shh signaling regulates palatal epithelial cell proliferation indirectly through, at least in part, activation of the fibroblast growth factor Fgf10 in the palatal mesenchyme [8] . Remarkably, in addition to regulating palatal epithelial cell proliferation, both Fgf10 and its epithelial receptor Fgfr2b are required for maintenance of Shh expression in the developing palatal epithelium [8] . Thus, Shh and Fgf10 signaling pathways function in a positive feedback loop to control palatal shelf growth [10] . In addition to its interaction with Fgf10 signaling, Shh signaling has also been shown to cooperate with Bmp signaling to regulate palatal shelf growth. In palatal explant culture assays, exogenous Shh protein induces Bmp2 mRNA expression [7] . Tissue-specific inactivation of Smo in the palatal mesenchyme caused down-regulation of Bmp2 expression in the anterior palatal mesenchyme [10] , indicating that Shh signaling is required for maintenance of Bmp2 expression during normal palatogenesis. Bmp signaling plays a critical role in anterior palatal shelf growth, as targeted deletion of Bmpr1a, encoding a type I receptor for Bmp ligands, in either the early neural crest or in the early palatal mesenchyme resulted in cleft of the anterior palate [11, 12] . Moreover, mice lacking the homeobox transcription factor Msx1 exhibit complete cleft palate that could be rescued by transgenic expression of Bmp4 driven by the Msx1 gene promoter [7] . During palatal shelf growth, the Msx1 -/-mutant mouse embryos showed reduced expression of Bmp4 in the anterior palatal mesenchyme as well as reduced expression of Shh in the anterior palatal epithelium, in comparison with wildtype embryos [7] . Transgenic Bmp4 expression in the anterior palatal mesenchyme was sufficient to restore Shh expression in the anterior palatal epithelium in the Msx1 -/-embryos, suggesting that Bmp4 acts downstream of Msx1 in the anterior palatal mesenchyme to maintain Shh expression in the anterior palatal epithelium [7] . The forkhead-box (Fox) family proteins form a large family of DNA-binding transcription factors [13, 14] . Through comparative transcriptional profiling of E10.5 embryonic head tissues of Shh mutant and control mouse embryos, Jeong et al. (2004) found that expression of several Fox family genes, including Foxc2, Foxd1, Foxd2, Foxf1, and Foxf2, in the neural crest derived facial mesenchyme was dependent on Shh signaling and suggested that these Fox family transcription factors might be key mediators of Hh pathway function in craniofacial development [9] . Both Foxf1 and Foxf2 are expressed in the developing palatal mesenchyme in wildtype mouse embryos and tissue-specific deletion of Smo also caused significant reduction in expression of Foxf1 and Foxf2 in the palatal mesenchyme [10, 15] . Foxf1 and Foxf2 display highly conserved amino acid sequences in the Forkhead DNA binding domain (100% identical in mouse and 97% identical in human FOXF subfamily) [16] [17] [18] . Whereas mouse embryos lacking Foxf1 function die during midgestation due to severe defects in the extraembryonic mesoderm [19] , mice lacking Foxf2 die shortly after birth with a cleft palate phenotype [15] . Mutations in FOXF2 have also been associated with cleft palate in humans [20] . However, how Foxf2 regulates palate development remains to be elucidated.
In this study, we show that Foxf1 and Foxf2 exhibit partially overlapping patterns of expression during palate development, with Foxf2 expressed more broadly than Foxf1 along the anterior-posterior axis of the developing palatal shelves. By using Cre/loxP mediated conditional gene inactivation, we demonstrate that the Foxf1 and Foxf2 transcription factors act partly redundantly to control palatal shelf growth through a novel Foxf-Fgf18-Shh regulatory circuit.
Results
Foxf2 is required in the neural crest-derived palatal mesenchyme for normal palatal shelf growth Wang et al. (2003) reported that Foxf2-deficient mice die shortly after birth and exhibit cleft palate. Although Wang et al. (2003) detected Foxf2 mRNA expression in the developing palatal shelves in wildtype mouse embryos, they found that Foxf2 mRNAs were more abundantly expressed in the muscle layers of the developing tongue and suggested that the cleft palate defect in Foxf2 -/-mice might be secondary to defects in tongue movement because the tongue did not properly descend in the mutant embryos [15] . To determine whether Foxf2 plays an intrinsic role in palate development, we generated mice with tissue-specific inactivation of Foxf2 in the cranial neural crest lineage or in the developing palatal mesenchyme using mice carrying a loxP-flanked Foxf2 conditional allele (Foxf2 c ) [21] . The Wnt1-Cre transgenic mice have been shown to exhibit Cre recombinase activity in the premigratory neural crest cells that give rise to most of the non-muscle mesenchyme in the craniofacial tissues [22] [23] [24] . On the other hand, the Osr2 IresCre/+ mice exhibit highly specific expression of the Cre recombinase in the Osr2-expressing palatal mesenchyme cells and with no Cre activity in the muscle cells of the developing tongue [10, 25] . We found that both Foxf2 c/-Wnt1-Cre and Foxf2 c/-Osr2
IresCre/+ mice have complete penetrance of cleft palate and many of the mutant embryos showed failure of palatal shelf elevation, similar to the cleft palate phenotype in mice with constitutive inactivation of the Foxf2 gene (Foxf2 -/-), (Fig 1) . These results suggest that Foxf2 function is required in the palatal mesenchyme for normal palatogenesis.
To investigate whether Foxf2 function is required for palatal shelf growth, we performed BrdU incorporation assays in E13.5 embryos. Since the developing palatal shelves exhibit morphological and molecular heterogeneity along the anterior-posterior and oral-nasal axes [1] , we analyzed the BrdU-labeling index separately for the oral and nasal halves of the palatal shelves in each of the anterior, middle, and posterior sub-regions, with the middle region corresponding to that flanked by the maxillary first molar tooth buds (Fig 2A-2F) . We found that Foxf2 -/-mutant embryos exhibited significant reduction in cell proliferation in the anterior region, nasal half of the middle region, and the posterior region of the palatal mesenchyme ( Fig  2G) . These data confirm an intrinsic role for Foxf2 in palate development.
Differential molecular effects of Foxf2 deficiency along the anteriorposterior axis of the developing palatal shelves
To gain insight into the molecular mechanisms mediating Foxf2 function in palate development, we analyzed whether the expression patterns of a number of genes known to play critical roles in palate development were altered in the Foxf2 -/-mutant palatal shelves. Shh signaling has been shown to regulate palatal shelf growth and Shh mRNA expression marks the palatal rugae, the epithelial ridges that form in specific spatiotemporal patterns on the oral surface of the palatal shelves during palatal outgrowth [10, 26, 27] . Thus, the whole mount Shh mRNA expression pattern has been used as a valuable molecular marker for analysis of palatal shelf growth or patterning defects in mutant mouse studies [12, [27] [28] [29] . In comparison with the Shh mRNA expression pattern in the palatal epithelium in wildtype embryos (Fig 3A and 3E) , the Foxf2 -/-mutant embryos exhibited specific loss of the most anterior Shh mRNA expression domain that corresponds to Ruga-3 ( Fig 3B and 3F) (Fig 3C, 3D, 3G and 3H) . We examined the expression patterns of Shox2 and Barx1, which mark the anterior and posterior halves of the developing palatal mesenchyme, respectively [27, 34, 35] . The level of Shox2 mRNA expression was reduced, especially in the anterior-most region of the palatal shelves, in Foxf2 -/-mutant embryos in comparison with the wildtype littermates (Fig 3I and 3J ). In contrast, the pattern and levels of expression of Barx1 in the developing palatal shelves were not obviously altered in Foxf2 -/-mutant embryos in comparison with the wildtype littermates ( Fig   3K and 3L) . Previous studies showed that the Msx1-Bmp4 and Fgf10 signaling pathways regulate palatal shelf growth as well as Shh mRNA expression in the palatal epithelium [7, 8, 28] . We examined whether palatal expression of these genes was affected by Foxf2 deficiency. By in situ hybridization analyses, however, we didn't detect obvious differences in expression of Msx1, Bmp4, and Fgf10, respectively, in the developing palatal shelves between Foxf2 -/-mutant and wildtype littermates (S1A-S1J Fig) . Moreover, we performed quantitative RT-PCR analysis of manually microdissected palatal shelves from E13.5 wildtype, Foxf2 +/-, and Foxf2 -/-littermates but did not detect any significant differences in expression levels of Bmp4, Fgf10, and Msx1 mRNAs, respectively, between the samples of different genotypes.
To gain a better understanding of the molecular mechanisms mediating Foxf2 function in palate development, we compared the transcriptome expression profiles of E13.5 Foxf2 -/-and control palatal mesenchyme by using RNA-seq analysis. To facilitate RNA-seq analysis of palatal mesenchyme cells, and since it has been shown that Foxf2 and Osr2 are expressed in a similar oral-to-nasal gradient pattern in the developing palatal mesenchyme at E13. Table) . Among these, Fgf18, which encodes a member of the fibroblast growth factor family ligands, was up-regulated by more than 2-fold in Foxf2
-/-Osr2 RFP/+ mutant palatal mesenchyme compared with the control littermates (S1 Table) . Subsequent quantitative real-time RT-PCR analysis validated the significantly increased expression of Fgf18 in the Foxf2 -/-mutant palatal mesenchyme ( Fig 4C) . Consistent with results from whole mount in situ hybridization, expression of Shox2 was significantly decreased whereas expression of Osr2 and Barx1 were not significantly changed in the Foxf2 -/-palatal mesenchyme in comparison with the control samples ( Fig 4C) .
We further compared the patterns of Fgf18 expression in the Foxf2 -/-and littermate control embryos by whole mount in situ hybridization. Strikingly, we found that Fgf18 mRNAs were ectopically expressed in specific anterior and posterior sub-regions of the developing palatal shelves in the Foxf2 -/-mutant embryos (Fig 5A and 5B ) that correspond to where expression of both Shh and Ptch1 was dramatically downregulated in the Foxf2 -/-mutant embryos in comparison with the control embryos (compare Fig 5A and 5B with Fig 3A-3H ). Further in situ hybridization analysis of serial coronal sections through the E13.5 palatal shelves confirmed ectopic expression of Fgf18 mRNAs in the palatal mesenchyme in the specific anterior and posterior regions in the Foxf2 -/-mutant embryos while Fgf18 mRNA expression in the wildtype littermates was restricted to the mesenchyme cells at the hinge region of the palatal shelves (Fig 5C-5F ). The molecular effects of Foxf2 deficiency on palate development correspond to distinct expression patterns of Foxf1 and Foxf2 in the developing palatal shelves
To understand why the Fox2 -/-mutant embryos exhibit region-specific changes in gene expression profiles along the anterior-posterior axis of the developing palatal shelves, we analyzed and compared the patterns of expression of Foxf2 and Foxf1 during palate development. From E12.5 to E13.5, Foxf1 mRNA expression was restricted to the middle region of developing palatal shelves, with the strongest level of expression detected in the molar tooth germs (Fig 6A and  6C ). In contrast, Foxf2 mRNA expression was detected throughout the anterior-posterior axis of the developing palatal shelves, with the posterior region of the palatal shelves exhibiting higher levels of expression than the anterior region at both E12.5 and E13.5 (Fig 6B and 6D) . We further analyzed the distribution of the Foxf1 and Foxf2 proteins in the developing palatal shelves by immunofluorescent detection in Osr2 RFP/+ knockin mouse embryos, which express the RFP reporter from the endogenous Osr2 locus that exhibits an oral-to-nasal gradient pattern of expression in the developing palatal mesenchyme [36] . At E13.5, Foxf1 protein is expressed at moderate levels in the mid-anterior region of the palatal mesenchyme while it is expressed very weakly in the anterior-most region and absent in the posterior region of the developing palatal shelves (Fig 6E-6H ). Foxf2 protein is distributed throughout the anteriorposterior axis of the palatal mesenchyme, but with different patterns along the oral-nasal axis in the anterior versus posterior regions (Fig 6I-6L ). In the anterior region up to the level of the molar tooth germs, Foxf2 protein distribution exhibited an oral-to-nasal gradient, with highest levels in the mesenchyme immediately underneath the palatal epithelium at the oral side ( Fig 6I, 6J and 6K ). In the palatal region posterior to the molar tooth germs, Foxf2 protein is expressed at high levels throughout the oral-nasal axis of the palatal mesenchyme (Fig 6L) . -/-mutant mouse embryos die during midgestation prior to palate morphogenesis [19] , which prevents a direct analysis of the role of Foxf1 in palate development in these mice, we generated and analyzed 
Exogenous Fgf18 protein inhibits Shh expression in the developing palate
We next investigated whether the ectopic Fgf18 expression in the palatal shelves could account for loss of Shh expression in the palatal epithelium in the Foxf2 -/-and Foxf1 c/c Foxf2 c/c
Wnt1-Cre mutant embryos. We placed Fgf18-soaked beads on the oral side of E13.0 palatal shelves in explant culture and examined effects of Fgf18 protein on Shh expression in the palatal epithelium after 24 hours of culture. As shown in Fig 8, application of Fgf18 protein caused a dramatic down-regulation of Shh gene expression in the palatal epithelium whereas the BSAsoaked beads did not have any obvious effect, as detected by in situ hybridization of Shh mRNA expression (Fig 8A) and by detection of GFP reporter expressed from the Shh GFP allele in Shh GFP/+ embryonic palates (Fig 8B) . These results, together with the corresponding domains of ectopic Fgf18 expression in the palatal mesenchyme and of loss of Shh expression in the palatal epithelium in the Foxf2 -/-and Foxf1 c/c Foxf2 c/c Wnt1-Cre mutant embryos, respectively, indicate that Foxf1 and Foxf2 regulate palatogenesis, at least in part, through repressing Fgf18 expression to maintain Shh signaling to stimulate palatal shelf growth.
Discussion
Shh signaling plays critical roles in the growth and patterning of the developing palatal shelves [8-10, 37, 38] . Disruption of the function of Shh, Smo, or the transcriptional effectors Gli2 or Gli3, during palatal development each causes cleft palate in the mutant mice [8, 10, 39, 40] , indicating that Shh signaling regulates palate development through Gli mediated transcriptional regulation. Whereas direct target genes of Gli transcription factors have not been specifically isolated from the developing palatal shelves, previous studies demonstrated that expression of the Foxf1 and Foxf2 in the craniofacial and palate mesenchyme dependent on Shh signaling [9, 10] . By using high-throughput sequencing of immunoprecipitated Gli3-bound chromatin fragments from developing mouse embryonic tissues, Hoffmann et al. recently showed that Gli3 bound to cis-regulatory sequences close to multiple Fox family genes, including Foxf1 [41] . Analysis of one of the Gli3-binding Foxf1 enhancer sequences driving lacZ reporter expression in transgenic mouse embryos showed specific enhancer activity in multiple Hedgehog responding tissues, indicating that Foxf1 is a direct target of Gli-mediated transcriptional regulation [41] (Fig 8C) . 
Differential expression and functional overlap between Foxf1 and Foxf2 in palate development
Although expression of both Foxf1 and Foxf2 mRNAs in the developing craniofacial and palatal mesenchyme depends on Shh signaling [9, 10] , we detected Foxf2 mRNA expression throughout the anterior-posterior axis of the developing palatal mesenchyme but Foxf1 mRNA expression is absent from specific anterior and posterior sub-regions of the developing palatal shelves, suggesting that other molecular pathways converge with the Shh signaling pathway to differentially regulate Foxf1 and Foxf2 expression during palate development. Consistent with this hypothesis, Hoffmann et al. (2014) recently identified a Foxf1 cis-regulatory element that bound both Gli1 and the T-box transcription factor Tbx5 in the developing heart tissues and that Gli1 and Tbx5 synergistically activated transcription from this cis-regulatory element [41] . In embryonic lung explant culture assays, Foxf1 mRNA expression in the lung mesenchyme was shown to be induced by Shh and repressed by Bmp4 [44] . We recently reported that Bmp4 is expressed in an anterior and a posterior subdomain of the developing palatal mesenchyme [29] . Future studies will determine whether Foxf1 expression during palate development is directly and antagonistically regulated by Shh and Bmp4 signaling.
Foxf2 plays an intrinsic role in palate development

Wang et al (2003) first showed cleft palate defect in the Foxf2
-/-mutant mice, but suggested that the cleft palate phenotype might be secondary to defects in tongue muscle development because Foxf2 mRNAs are abundantly expressed in the muscle layers of the developing tongue in wildtype mouse embryos, and because they did not detect a significant difference in cell proliferation in the developing palate at E13.5 and E15.5 using BrdU labeling. Our analysis of BrdU labeling of the palatal mesenchyme detected significant reduction in palatal mesenchyme proliferation at E13.5, at the peak of palatal shelf growth. The discrepancy in these findings are most likely due to differences in the BrdU labeling procedure and in data analysis. We injected the pregnant mice intraperitonially with 50 μg/g body weight BrdU and harvested the embryos one hour later. This procedure resulted in labeling of up to 40% of the palatal mesenchyme cells in E13.5 wildtype embryos. In contrast, Wang et al. (2003) injected the pregnant mice intraperitonially with 100 μg/g body weight and sacrificed the injected animals 2 hours later. At E13.5, this procedure might have saturated labeling of the palatal mesenchyme cells. In addition, since the developing palatal shelves have both morphological and molecular heterogeneity [1] , we recorded the percentage of BrdU-labeled palatal mesenchyme cells on serial sections throughout the palatal shelves and analyzed the data separately in the six regions along the anterior-posterior and oral-nasal axes. It is not clear how Wang et al. analyzed the BrdUlabeling data. Given the heterogeneity of the palatal mesenchyme and our finding that the molecular effects of Foxf2-deficeincy on the developing palatal shelves are most pronounced in the anterior and posterior domains where Foxf2, but not Foxf1, is expressed during normal palatogenesis, it is possible that simple analysis of the BrdU-labeling index in the middle region of palatal shelves would not find significant differences in the mutant and control embryos. Indeed, our data show that cell proliferation index is not significantly different in the mid-oral portion of the developing palatal shelves in the Foxf2 -/-and control littermates (Fig 2G) . The differential effects of loss of Foxf2 function on palatal cell proliferation along the anterior-posterior axis is mostly likely due to partial functional compensation by Foxf1 in the middle region of the developing palatal shelves. The fact that the Foxf1 c/c Foxf2 c/c Wnt1-Cre compound mutant embryos exhibit only rudimentary palatal shelves supports the conclusion that Foxf1 and Foxf2 act partly redundantly to control palatal shelf growth.
Our conclusion that Foxf2 plays an intrinsic role in palate development is also supported by the molecular effects of Foxf2-deficiency on palatal gene expression. The domain-specific changes in Fgf18 and Shh expression in the developing palatal shelves in the Foxf2 -/-mutant embryos correlated with the lack of Foxf1 expression in the anterior and posterior regions of the palatal mesenchyme. Moreover, we found that Foxf1 c/c Foxf2 c/c Wnt1-Cre embryos exhibit ectopic Fgf18 mRNA expression specifically throughout the palatal mesenchyme and loss of Shh mRNA expression throughout the palatal epithelium. Thus, similar to their functions in gut and heart development in which Foxf1 and Foxf2 exhibit synergistic effects [41, 43] , Foxf1 and Foxf2 could partly complement for each other's function during palate development in the regions where they exhibit overlapping expression. Whereas the cell proliferation and molecular studies clearly demonstrate an intrinsic role for Foxf2 in palate development, both Foxf2 c/-Wnt1-Cre and Foxf2 c/-Osr2 IresCre/+ embryos exhibit defects in palatal shelf elevation and abnormal tongue shape (Fig 1G and 1H) . Whereas the Foxf2 c/-Wnt1-Cre embryos are expected to have loss of Foxf2 function throughout the neural crest-derived craniofacial mesenchyme, including the non-muscle connective tissues in the tongue, which could cause a primary defect in tongue development, the Osr2 IresCre/+ embryos exhibit only limited Cre activity in a subset of tongue mesenchyme cells directly underlying the tongue epithelium [10, 25] . However, it is possible that loss of Foxf2 function in the small population of tongue mesenchyme cells directly underlying the epithelium also perturbs epithelialmesenchymal interactions during tongue development. Thus, whether disruption of Foxf2 function in the developing tongue could secondarily affect palatal shelf elevation remains to be investigated by generation and analysis of mice with tissue-specific inactivation of Foxf2 in the developing tongue.
A Shh-Foxf-Fgf18-Shh regulatory circuit in the molecular network controlling palate development
Our RNA-seq analysis of Foxf2 -/-and control embryonic palatal mesenchyme revealed that Foxf2-deficiency significant affected the expression of over 150 genes in the developing palate. Our in situ hybridization analysis revealed the striking pattern of ectopic Fgf18 expression in the Foxf2 -/-mutant palate, which correlated well with the unique domains of Foxf2, but not Together with the findings that exogenous Fgf18 protein inhibited Shh expression in palatal explant culture and our previously reported data that expression of Foxf1 and Foxf2 in the palatal mesenchyme depends on Shh signaling [10] , these results identify a novel negative feedback loop controlling Shh expression during palate development. Fgf18 belongs to the fibroblast growth factor family of ligands, which consists of 22 members and signal through alternatively spliced forms of tyrosine kinase receptors encoded by four distinct genes, Fgfr1, Fgfr2, Fgfr3, and Fgfr4 [45, 46] . Previous studies have implicated Fgf7 and Fgf10 in the regulation of Shh expression during palate development [8, 28] . Whereas Fgf7 and Fgf10 share high amino acid sequence homology and both signal exclusively through the Fgfr2b receptor in epithelial tissues, they elicit distinct and sometime opposite cellular responses in developmental tissues as well as in cell culture assays [8, 28, 47, 48] . During palate development, Fgf7 and Fgf10 exhibit complementary expression patterns in the developing palatal mesenchyme, with Fgf7 mRNAs preferentially expressed in the nasal side and Fgf10 mRNAs restricted to the oral side of the palatal mesenchyme [8, 28] . Mice lacking Fgf10 or Fgfr2b exhibit cleft palate, with loss of Shh expression in the developing palatal epithelium [8] . In palatal explant culture assays, exogenous Fgf10 protein induced, whereas exogenous Fgf7 protein repressed, Shh mRNA expression, suggesting that Fgf7 antagonizes Fgf10 function to restrict Shh expression to the oral side of the palatal epithelium [8, 28] . Although the mechanism underlying the opposite effects of Fgf7 and Fgf10 on Shh expression during palate development is not known, Francavilla et al. (2013) recently reported that Fgf10 specifically induced rapid phosphorylation of the tyrosine (Y)-734 residue on Fgfr2b, which led to the receptor recycling and enhanced and prolonged Fgfr signaling, whereas Fgf7 led to rapid degradation of the receptors [48] . It is plausible that inhibition of Shh expression in the palatal explant by exogenous Fgf7 could be mediated by Fgf7-induced Fgfr2b degradation, as Fgfr2b function is required for maintenance of Shh expression in the palatal epithelium [8] . It is possible that the ectopically expressed Fgf18 in the Foxf2 -/-and Foxf1 c/c Foxf2 c/c Wnt1-Cre mutant palatal mesenchyme might also cause reduction in Shh expression in the palatal epithelium by inducing rapid Fgfr2b degradation. However, in vitro studies and prediction from crystal structures suggested that Fgf18 lacks affinity for Fgfr2b [49, 50] . On the other hand, Fgf18 has been shown to bind Fgfr3c and the cysteine-rich Fgf receptor [51, 52] . The detailed molecular mechanism involving Fgf18-mediated regulation of Shh expression during palate development requires further investigation. Interestingly, mice lacking Fgf18 function exhibit high penetrance of cleft palate [53, 54] . Moreover, genome-wide association studies of cleft lip and palate in humans have shown disease association with the FGF18 locus [55] . Thus, further investigation of the role and molecular mechanisms involving Fgf18 in palate development will directly improve our understanding of the genetic basis and molecular mechanisms of cleft palate pathogenesis in humans.
Materials and Methods
Mouse strains
The Foxf1 c/c , Foxf2 c/c , Wnt1-Cre and Osr2 IresCre/+ mice have been described previously [21, 22, 25, 56] . 
Histology and immunofluorescent staining
For histological analysis, embryos were dissected at desired stages from timed pregnant mice, fixed in 4% paraformaldehyde (PFA), dehydrated through an ethanol series, embedded in paraffin, sectioned at 7μm thickness, and stained with alcian blue followed by hematoxylin and eosin. Immunofluorescent staining of paraffin sections was performed following standard protocols. Antibodies used are: rabbit anti-RFP (MBL international, PM005), Goat anti-Foxf1 (R&D, AF4798), and sheep anti-Foxf2 (R&D, AF6988).
Cell proliferation assays
To determine cell proliferative activity in the developing palatal shelves, timed pregnant mice were injected intraperitoneally with BrdU (5 mg/ml stock solution, 10 μl/g body weight) (Sigma-Aldrich). Embryos were harvested 1 hour after injection, fixed with 4% PFA, paraffin embedded and sectioned at 7 μm. The BrdU-labeling index was defined as the number of BrdU-positive nuclei relative to total nuclei, which was co-stained by DAPI. The cell proliferation data were recorded from seven sections from each of the anterior, middle and posterior regions of each palatal shelf, and also analyzed separately for the oral and nasal halves of each region of the palatal shelves in each embryo. Data from two independent litters, each containing two wildtype and two Foxf2 -/-embryos, were used for statistical analysis.
In situ hybridization
Whole mount and section in situ hybridization was performed as previously described [36, 57] . At least three embryos of each genotype were hybridized to each probe and only probes that detected consistent patterns of expression in all samples were considered as valid results.
Palatal shelf explant culture and bead implantation
Palatal shelf explant culture and bead implantation experiments were carried out using a previously described protocol with minor modification [28] . Briefly, Timed pregnant mice were sacrificed on post-coital day 13.0 (E13.0). The embryonic maxillary processes with the secondary palatal shelves were manually microdissected and cultured in BGJb medium supplementary with 10 U/ml penicillin/ streptomycin (Invitrogen), 50 mM transferrin (Sigma) and 150 μg/ml ascorbic acid (Sigma). For bead implantation, Affi-Gel blue agarose beads (BioRad) were soaked in recombinant Fgf18 proteins (1mg/ml, Peprotech), or BSA (1mg/ml) as control. Tissues were harvested after 24 hours of culture at 37°C at an atmosphere of 5% CO2 and 100% humidity and fixed in 4% paraformaldehyde for whole mount in situ hybridization experiments.
Fluorescence activated cell sorting and RNA-seq 
Foxf2
+/-Osr2 RFP/+ and Osr2 RFP/+ samples were used as controls. Sequencing libraries were generated by using Illumina Nextera DNA Sample Prep kit and sequenced using Illumina HisEq 2000. Sequence reads were mapped to the reference mouse genome (mm9) using Bowtie. Single-end reads were aligned using Tophat. RNA-seq data were then analyzed using Strand NGS software, with the reads per kilobase exon per million mapped sequences value calculated for each RefSeq gene for relative levels of gene expression. For analyses of differential expression, the fold-change cutoff was set at 1.5 or higher. P value less than 0.05 from the Audic Claverie test was considered statistically significant, with Benjamini-Hochberg false discovery rate multiple testing correction [58] . The original RNA-seq data files from this study have been deposited into the National Center for Biotechnology Information Gene Expression Omnibus (NCBI GEO) database (accession number GSE67015).
Real-time RT-PCR
First-strand cDNAs were synthesized using SuperScript First-Strand Synthesis System (Invitrogen, 11904-018). Primers for specific transcripts were designed for real-time RT-PCR (SYBR). β-Actin was used as internal control in each reaction. Real-time PCR was performed using a Bio-Rad CFX96 Real-Time System using conditions recommended by the manufacturer. Each reaction was performed in duplicate. The quantity of each mRNA was first determined using a standard curve method and normalized to the internal control. The primers used for real-time RT-PCR are listed in S2 Table. Statistical analysis
All results were presented as mean ± SEM. All statistical analyses were done using Excel software. Two-tailed Student's t tests were used for comparisons between two groups. P value less than 0.05 was considered significant.
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